Find Academic Supervisors

Shannon F.R. Small, MD, is an Assistant Professor in the Department of Surgery at Yale School of Medicine, specializing in General Surgery, Trauma, and Surgical Critical Care. She practices at Yale Medicine and provides comprehensive surgical care ranging from trauma and emergency cases to elective and robotic procedures. Institution: Yale University School: Yale School of Medicine Department: Department of Surgery Academic Rank: Assistant Professor Email: shannon.small@yale.edu Dr. Small's research and clinical work focus on improving patient outcomes through advanced surgical techniques, particularly in trauma and critical care settings. She has a strong interest in pain management for rib fractures and expanding access to surgical care. Her work integrates robotic surgery to enhance precision and recovery in procedures such as gallbladder removal, hernia repair, and bowel perforations. Her recent publications highlight expertise in minimally invasive and robotic surgery, pediatric surgical conditions, and trauma care protocols. Themes across her research include innovation in surgical technique, global health applications, and evidence-based implementation of clinical guidelines. Scientific Awards: No awards listed in the provided text. Dr. Small is actively involved in mentoring future surgeons and promoting inclusive excellence in medicine. She emphasizes compassionate, equitable care guided by the principle of treating patients as she would her own family. She is board certified in General Surgery and Surgical Critical Care by the American Board of Surgery (2017) and maintains an active clinical and academic role at Yale. Labs and Teams: No specific lab affiliations mentioned. Active participant in the Department of Surgery’s trauma and critical care team at Yale School of Medicine.

• Trauma Surgery
• Surgical Critical Care
• General Surgery
• +7 more

Mehmet Keskin is a Professor at Gaziantep University Faculty of Medicine, Department of Internal Medicine and Department of Child Health and Diseases. His primary research focus is in Pediatric Endocrinology, with particular expertise in thyroid disorders, diabetes, growth disorders, and adrenal diseases in children. Dr. Keskin completed his medical education at Hacettepe University Faculty of Medicine (1986-1995), followed by medical specialization in Child Health and Diseases at the same institution (1996-2001). He further specialized in Pediatric Endocrinology at Erciyes University (2002-2005). Since 2006, he has served as a Professor at Gaziantep University. His research interests span multiple areas of pediatric endocrinology including thyroid disorders (particularly congenital hypothyroidism and thyroid nodules), diabetes mellitus (especially Type 1 diabetes and its complications), adrenal disorders (including congenital adrenal hyperplasia), growth disorders, puberty disorders, and metabolic diseases. His work often focuses on the Turkish population, particularly in Southeastern Anatolia. Dr. Keskin has published extensively with over 150 articles in international journals, with recent work focusing on genetic aspects of endocrine disorders, genotype-phenotype correlations, and epidemiological studies of endocrine conditions in Turkish children. His research shows a strong emphasis on translating genetic findings into clinical practice and improving screening programs for endocrine disorders. He has authored or co-authored 5 book chapters on pediatric endocrinology topics, including works on thyroid diseases, adrenal disorders, and metabolic diseases in children. Dr. Keskin's work has significant clinical implications for the diagnosis and management of pediatric endocrine disorders in Turkey and contributes to the global understanding of these conditions, particularly in understudied populations.

• Pediatric Endocrinology
• Child Health and Diseases
• Thyroid Disorders
• +5 more

Natalie Allen, MD is an Assistant Professor in the Department of Pediatrics at Penn State College of Medicine . She actively contributes to pediatric endocrinology research, focusing on topics such as vaginal microbiome variations, gonadotropin-releasing hormone therapy, and differences of sex development. Her work aligns with UN Sustainable Development Goals related to health and well-being. Education: Temple University (MD, 2014) Training: Virginia Commonwealth University Health System (Residency 2017, Fellowship 2020) Research interests include: Pediatric endocrinology Overweight/obesity in reproductive age women Hormone analog therapy Vaginal microbiome studies Recent publications span 2017–2024, covering: Precocious puberty treatment Vaginal bleeding in prepubescent girls Thyroid nodule analysis Microbiome weight-related health impacts Awarded the Dean's Award for Excellence in Teaching (2024) , Dr. Allen maintains active collaborations and has received recognition in medical education circles.

• Pediatric Endocrinology
• Vaginal Microbiome
• Overweight/Obesity Research
• +5 more

Dianne Deplewski serves as an Associate Professor within the Department of Pediatrics-Endocrinology at the University of Chicago. Her academic and clinical work bridges molecular endocrinology and pediatric care, with over 30 years of research spanning sebaceous gland biology to contemporary metabolic disorders in children. Her research portfolio prominently features pediatric obesity, type 1 and type 2 diabetes, polycystic ovary syndrome (PCOS), growth disorders, and vitamin D metabolism. Early career work established foundational knowledge on hormonal regulation of pilosebaceous unit development, particularly androgen and growth factor mechanisms in sebocyte differentiation. Current investigations focus on metabolic syndrome complications, endocrine management in inflammatory bowel disease, and rare diabetes presentations in adolescents. Publication trends reveal a strategic evolution from basic science (1995-2007) exploring nuclear hormone receptors and lipogenic pathways to clinically oriented research (2014-2025) addressing obesity screening protocols, diabetes complications, and endocrine manifestations in genetic syndromes. Her 2023-2025 work includes high-impact case reports on atypical diabetes presentations and systematic reviews of metabolic consequences in pediatric populations.

• Pediatric Endocrinology
• Obesity in Children
• Type 1 Diabetes
• +6 more

Lily C. Chao, MD is a Clinical Associate Professor of Pediatrics at the University of Southern California. Her research focuses on mechanisms regulating muscle metabolism and growth, particularly the role of the nuclear receptor Nur77 (NR4A1) in skeletal muscle and its implications for conditions like diabetes and muscle wasting. She leads studies on Nur77's role in glucose utilization, muscle regeneration, and diabetic myopathy. Research Interests: Dr. Chao's work integrates metabolism and muscle mass signaling, with translational applications in diabetes, muscular dystrophy, and cachexia. Key projects investigate Nur77's function in muscle development and diabetic complications. Publications Trends: Her recent articles address youth-onset type 2 diabetes, pandemic impacts on pediatric metabolic disorders, and advancements in diabetes technology (e.g., insulin pumps, continuous glucose monitors). Studies emphasize healthcare disparities, treatment efficacy, and pandemic-related clinical challenges. Awards: Early Investigator Award (Endocrine Society, 2014) Clinical Research Scholar (Pediatric Endocrine Society, 2013) Pasadena Magazine’s Top Doctors (2011–2014) Fellow’s Basic Research Award (Society of Pediatric Research, 2007) Howard Hughes Medical Institute-NIH Research Scholar (1999) Advising & Grants: While specific grants are not listed, her publications suggest involvement in multi-institutional trials (e.g., TODAY study) and NIH-funded research. She collaborates broadly in pediatric endocrinology and diabetes care innovation. Labs/Teams: Her research is conducted within the CHLA-Saban Research Institute, focusing on translational pediatric endocrinology and metabolic disorders.

• Muscle Metabolism
• Glucose Utilization
• Diabetes Research
• +3 more

Dr. Violeta Heras Domínguez is a Researcher affiliated with the Department of Physiology and the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS) at the University of Córdoba. She holds a PhD (2019) from the same institution, focusing on 'New regulatory mechanisms of the central control of puberty: analysis of the role of ceramide signaling and the mkrn3/mir-30b system,' supervised by Dr. Manuel José Tena Sempere and Dr. Juan Manuel Castellano. Her work primarily investigates the neuroendocrine regulation of puberty, metabolic pathways in obesity, and molecular mechanisms linking metabolic dysfunction to reproductive health. She is part of the MetaMol group studying Molecular Metabolism. Research interests include: (1) Central nervous system signaling pathways regulating puberty timing, (2) Metabolic syndrome comorbidities with reproductive disorders, (3) Epigenetic regulation of hypothalamic neurons, (4) Role of ceramides and lipid mediators in developmental physiology. Her recent work emphasizes sex-specific metabolic responses, gut-brain axis interactions, and therapeutic targets for fibrosis and non-alcoholic fatty liver disease (NAFLD). Publications highlight interdisciplinary approaches combining molecular biology, mouse models, and clinical correlations. Key findings include obesity-induced precocious puberty mechanisms, FGF21's role in breastfeeding benefits, and p63's involvement in hepatic fibrosis. Research has been published in high-impact journals with a focus on endocrinology, physiology, and molecular medicine. Advising/Grants: No specific students or grants listed in provided texts. Lab affiliations include CIMUS and MetaMol group collaborations. Current projects likely involve extending puberty regulation studies to translational medicine applications.

• Metabolic Regulation
• Puberty Physiology
• Obesity Pathophysiology
• +3 more

Taneli Raivio serves as Professor in the Department of Physiology at the Faculty of Medicine, University of Helsinki, where he leads the Raivio Group and contributes to the STEMM - Stem Cells and Metabolism Research Program. He holds dual appointments as Supervisor for the Doctoral Programme in Biomedicine and the Doctoral Programme in Clinical Research at HUS Children and Adolescents, and holds the title of Docent at Clinicum. His research focuses on pediatric endocrine disorders, particularly congenital hypogonadotropic hypogonadism and precocious puberty, with significant contributions to understanding hormonal impacts on bone development and growth. His molecular work explores genetic variants affecting pituitary and pancreatic hormone expression, while his clinical trials investigate aromatase inhibition and growth prediction methodologies. The Raivio Group integrates clinical epidemiology with stem cell research, notably in kisspeptin neuron generation. Recent publications (2024-2025) reveal a strong emphasis on translational endocrinology, combining clinical trials in pediatric bone health with molecular genetics of endocrine disorders. His work demonstrates consistent focus on puberty disorders across demographic trends, hormonal mechanisms, and therapeutic interventions, with increasing integration of stem cell models since 2023. Professor Raivio currently directs two major research projects: the Sigrid Jusélius Foundation-funded Raivio Juselius 2025-2028 (€58,000, 2025-2026) and an Academy of Finland Academy Project on Generation of kisspeptin neurons from human pluripotent stem cells (2025-2029). He has supervised 8 doctoral theses and scholarly works through the Biomedicine and Clinical Research doctoral programs. As leader of the Raivio Group within the STEMM consortium, he collaborates across clinical and basic science domains, maintaining active partnerships with HUS Children and Adolescents and international endocrine research networks. His team employs multidisciplinary approaches spanning clinical epidemiology, molecular genetics, and stem cell modeling to address fundamental questions in reproductive endocrinology.

• Pediatric Endocrinology
• Congenital Hypogonadotropic Hypogonadism
• Precocious Puberty
• +3 more

Amira Ramadan is an Instructor of Pediatrics at Harvard Medical School and an Attending Physician in the Division of Endocrinology at Boston Children’s Hospital. She holds clinical and academic roles focused on pediatric endocrinology, diabetes, and bone health. Her education includes a medical degree from Ain Shams University (Egypt), residencies at Tufts Medical Center and Ain Shams University, and a pediatric endocrinology fellowship at the University of North Carolina. Dr. Ramadan’s research emphasizes health equity in pediatric densitometry, asthma management, and adaptations in diabetes care during global health crises. She contributes to programs like the Bone Health Program and Diabetes Program at Boston Children’s Hospital. Her work addresses racial biases in clinical guidelines, environmental impacts on asthma, and telemedicine innovations during the pandemic. She is fluent in Arabic and English, and her clinical interests span Addison’s disease, growth disorders, and precocious puberty. Dr. Ramadan’s publications reflect interdisciplinary approaches to pediatric care, combining clinical practice with public health perspectives.

• Pediatrics
• Endocrinology
• Bone Health
• +4 more

Dr. Sasha Howard is a Clinical Reader (Associate Professor) in Paediatric Endocrinology at Queen Mary University of London and an Honorary Consultant at Barts Health NHS Trust. Her research focuses on genetic and hormonal mechanisms underlying pubertal disorders, including central precocious puberty (CPP) and delayed puberty (DP). She leads the Genetics of Disordered Puberty Project, identifying genetic mutations responsible for these conditions, with a current cohort of >130 patients yielding a 28% diagnostic rate. Clinically, she runs specialist puberty services and developed national guidelines for pubertal disorder management. Education: MBBS (Distinction, UCL, 2004); PhD in Molecular Endocrinology (Wellcome Trust-funded, 2017); Advanced clinical training in Paediatrics and Paediatric Endocrinology at Barts Health, UCLH, and Great Ormond Street Hospitals. She holds leadership roles as Integrated Academic Training lead for QMUL’s Specialised Foundation Programme and senior lead for the pan-London REACH paediatric research network. Research interests span genetic mapping of puberty timing, gonadotropin therapy efficacy (e.g., the PinG Study), and neurodevelopmental syndromes linked to puberty disorders. Her group explores genes like IGSF10, SEMA6A, and BRINP2, with translational projects aiming to improve diagnostic tools and fertility outcomes for patients with hypogonadism. Awards include the 2021 Wellcome Trust Clinical Research Fellowship, 2017 NIHR Clinical Lectureship, and multiple grants from NIHR, Rosetrees Trust, and the Academy of Medical Sciences. Collaborations involve Imperial College London, Great Ormond Street Hospital, and international networks like the European Society for Paediatric Endocrinology (ESPE). Teaching and mentorship: Supervises PhD students and clinical trainees, with alumni now in academia (e.g., Harvard postdocs) and clinical roles worldwide. She co-leads the Barts Pituitary Centre and chairs the NIHR/BSPED Clinical Studies Group.

• Pediatric Endocrinology
• Genetic basis of puberty disorders
• Hormonal signaling and development
• +3 more

Astrid Bruun Rasmussen serves as a Senior Consultant ( Afdelingslæge ) at the Department of Paediatrics, Faculty of Medicine, Aalborg University Hospital. Her dual clinical-academic role positions her at the forefront of paediatric endocrinology research and patient care. Her research concentrates on complex endocrine disorders in children, with major contributions in two areas: Turner Syndrome : Investigating clinical phenotypes, diagnostic challenges, and physical manifestations through visual documentation. Hypoparathyroidism : Exploring genetic etiologies, parathyroid hormone dysfunction, and diagnostic protocol improvements via generational assay transitions. Analysis of her 2022-2025 publications reveals a consistent focus on rare genetic endocrine conditions. She employs case reports and molecular analyses to bridge clinical presentation with genetic mechanisms, particularly in hypoparathyroidism and Turner Syndrome. Her work demonstrates practical impacts on diagnostic criteria, as evidenced by studies on PTH assay generations influencing genetic diagnosis pathways. Dr. Rasmussen maintains active institutional collaborations, co-authoring with researchers across endocrinology and genetics, though specific grant funding details remain undisclosed in available records.

• Paediatric Endocrinology
• Turner Syndrome
• Hypoparathyroidism
• +3 more

Sena Cantas Orsdemir, MD is an Assistant Professor in the Department of Pediatrics at Loma Linda University School of Medicine. She also serves as Head of the Pediatric Endocrinology Division. Education: Doctor of Medicine, University of Ankara (2009) Her research focuses on pediatric endocrinology, particularly growth hormone therapy, central precocious puberty, and diabetes management in children. She has published extensively on these topics. Recent publications highlight her work on optimizing growth hormone treatment during puberty, diagnostic imaging in endocrine disorders, and telemedicine applications for Type 1 Diabetes Mellitus. She has contributed to systematic reviews and meta-analyses in her field. She actively participates in professional societies, including the Pediatric Endocrine Society and SCOPE, and leads community initiatives such as the Annual Diabetes Education for School Nurses program.

• Pediatric Endocrinology
• Growth Hormone Therapy
• Central Precocious Puberty
• +3 more

Björn Brunström is a Professor at Uppsala University's Department of Organismal Biology, specializing in Physiology and Environmental Toxicology. His research focuses on the effects of environmental contaminants on wildlife, particularly examining endocrine disruption in birds and fish models. His research interests span environmental toxicology, endocrine disruption, reproductive toxicology, developmental toxicology, wildlife toxicology, and chemical risk assessment. Brunström's work investigates how chemicals like bisphenols, perfluoroalkyl substances, pharmaceuticals, and progestins affect developmental processes, reproductive systems, and metabolic functions in various animal models, with particular emphasis on avian species and zebrafish. Analysis of his recent publications reveals consistent focus on endocrine disrupting chemicals and their effects on developmental processes across multiple species. His research often examines molecular mechanisms, particularly cytochrome P450 enzymes, estrogen receptor pathways, and developmental signaling systems. He has made significant contributions to understanding how chemical mixtures affect biological systems, moving beyond single-chemical studies to more environmentally relevant exposure scenarios. Brunström has been involved in numerous collaborative research projects examining environmental contaminants, with particular expertise in avian toxicology and fish models. His work has important implications for environmental risk assessment of chemicals and understanding how human-made substances impact wildlife populations. His research has been published extensively in high-impact journals including Chemosphere, Toxicological Sciences, and Aquatic Toxicology, demonstrating his significant contributions to the field of environmental toxicology.

• Environmental Toxicology
• Endocrine Disruption
• Reproductive Toxicology
• +5 more

Britta Svoren, M.D., serves as Associate Professor of Clinical Pediatrics (Part-Time) in the Department of Endocrinology at the University of Rochester School of Medicine and Dentistry. She is actively affiliated with the University of Rochester Medical Faculty Group (URMFG) and Accountable Health Partners (AHP), providing specialized care for children, adolescents, and young adults with diabetes and endocrine disorders while maintaining a 4.9/5 patient satisfaction rating. Her academic foundation includes: MD from SUNY at Buffalo-School of Medicine & Biomedical Sciences (2000) Comprehensive training at Boston Children's Hospital: Internship (2000-2001), Residency (2001-2003), and Pediatric Endocrinology Fellowship (2003-2006) Dr. Svoren's research program focuses on preventing type 1 diabetes complications while preserving pediatric growth, development, and family functioning. She investigates environmental triggers of pancreatic autoimmunity and leverages continuous glucose monitoring technologies to optimize diabetes management, balancing clinical innovation with family-centered care approaches. Her publication history (2003-2009) reveals consistent emphasis on pediatric diabetes pathophysiology and management, with recurring themes in autoimmune mechanisms, technology integration, and complication prevention across diverse clinical scenarios including vitamin D deficiency, insulin pump durability, and endocrine disruptions from environmental exposures. Her scientific recognition includes: Harvard Medical School Scholars in Medicine Fellowship Award (2007) Eli Lilly and Company Fellowship Research Training Grant (2004) NIH Pediatric Research Loan Repayment Grant (2003-2007) Children's Hospital of Buffalo Prize (2000) Alpha Omega Alpha Honor Society (2000) Dean's List for Academic Excellence (1997-1999) Phi Beta Kappa Honor Society (1994) Dr. Svoren has secured significant research funding through NIH and industry partnerships to advance pediatric diabetes care, with her clinical excellence consistently reflected in patient testimonials praising her thorough explanations, collaborative decision-making, and compassionate approach to complex endocrine conditions in young patients.

• Type 1 Diabetes
• Pediatric Endocrinology
• Diabetes Complications
• +3 more

Micahlis Picolos is a Clinical Associate Professor of Endocrinology at the School of Medicine, European University Cyprus. His research focuses on endocrine disorders, diabetes, thyroid diseases, and genetic aspects of metabolic conditions. He has contributed to studies on diabetes management, thyroid hormone resistance, and congenital adrenal hyperplasia. His work often addresses clinical applications such as hybrid closed-loop systems for diabetes and guidelines for thyroid nodule diagnosis. Key research interests include: Genetic defects in endocrine disorders Thyroid dysfunction and metabolic outcomes Clinical trials for diabetes therapies His publications analyze topics like hyperthyroidism treatment impacts, Epstein-Barr virus interactions in diabetes, and CYP21A2 gene variants. He has led projects on ATA guidelines for thyroid nodule management and epidemiological studies on hypoglycemia in Cyprus. His research bridges clinical practice with genetic and molecular advancements.

• Endocrinology
• Diabetes Research
• Thyroid Disorders
• +3 more

Natalie Allen is an Assistant Professor in the Department of Pediatrics , focusing on pediatric endocrinology and women's reproductive health. Her research explores topics such as vaginal microbiome dynamics, obesity impacts on reproductive health, and clinical management of hormone-related conditions in children. She has contributed to peer-reviewed journals and reviews, addressing areas like isolated vaginal bleeding before puberty and benign hyperphosphatasemia. Research Interests: Her work spans Overweight/Obesity , Vaginal Microbiome , Hormone Therapy in Children , and Sex Development Disorders . She actively collaborates on studies linking microbiota composition to metabolic health and endocrine disorders. Awards: She received the Dean's Award for Excellence in Teaching (2024) , recognizing her contributions to medical education. Publications: Her articles analyze clinical cases, diagnostics, and therapeutic approaches, reflecting a focus on translating research into pediatric care practices.

• Pediatrics
• Endocrinology
• Obesity Research
• +5 more